Estimates Revisions HBM Healthcare Investments AG
Stocks
HBMN
CH0012627250
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 249.50 CHF | 0.00% |
|
+2.67% | +10.15% |
| 07-07 | Fore Biotherapeutics Inc. announced that it has received $110 million in funding from a group of investors | CI |
| 07-02 | HBM Healthcare Investments Expects CHF238 Million Profit for Fiscal Q1 | MT |
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- HBMN Stock
- Consensus HBM Healthcare Investments AG
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition